INTERNATIONAL PATENT: UNIQURE BIOPHARMA B.V. FILES APPLICATION FOR "NUCLEIC ACID FOR A1AT REGULATION"

GENEVA, Oct. 27 -- UNIQURE BIOPHARMA B.V. (Paasheuvelweg 251105 BP Amsterdam) filed a patent application (PCT/EP2025/060487) for "NUCLEIC ACID FOR A1AT REGULATION" on Apr 16, 2025. With publication no. WO/2025/219443, the details related to the patent application was published on Oct 23, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DE SOUSA MONTENEGRO MIRANDA, Paula (c/o uniQure biopharma B.VPaasheuvelweg 251105 BP Amsterdam), GALMES, Romain Pascal (c/o uniQure biopharma B.V.Paasheuvelweg 251105 BP Amsterdam), WARTEL, Morgane Sarah (c/o uniQure biopharma B.V.Paasheuvelweg 251105 BP Amster...